Northern Trust
LEXX icon

Northern Trust’s Lexaria Bioscience LEXX Stock Holding History

Northern Trust’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Hold
1,226
– – ﹤0.01% 4356
2025
Q4 		$11.3K Hold
1,226
– – ﹤0.01% 4429
2025
Q3 		$17.5K Hold
1,226
– – ﹤0.01% 4385
2025
Q2 		$16K Hold
1,226
– – ﹤0.01% 4355
2025
Q1 		$31.4K Hold
1,226
– – ﹤0.01% 4292
2024
Q4 		$38.6K Hold
1,226
– – ﹤0.01% 4297
2024
Q3 		$56.1K Hold
1,226
– – ﹤0.01% 4184
2024
Q2 		$51.1K Hold
1,226
– – ﹤0.01% 4208
2024
Q1 		$66.8K Buy
+1,226
New +$46.9K ﹤0.01% 4176

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Northern Trust's LEXX Position: Q1 2026 in Review

Northern Trust held its Lexaria Bioscience (LEXX) position steady in Q1 2026 at 1,226 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4356.

Northern Trust first reported a position in LEXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $66.8K in Q1 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Northern Trust held 1,226 shares of Lexaria Bioscience worth $14.3K as of Q1 2026.
  • Northern Trust left its Lexaria Bioscience share count unchanged in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4356 holding.
  • Northern Trust first reported a position in Lexaria Bioscience in Q1 2024 and has held it in 9 quarters since.
  • Northern Trust's Lexaria Bioscience position peaked at $66.8K in Q1 2024.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.